| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.93B | -0.8% |
| Cost of Revenue | $811.8M | -12.4% |
| Gross Profit | $983.0M | +13.9% |
| R&D Expense | $279.3M | +15.3% |
| SG&A Expense | $176.1M | +28.1% |
| Operating Income | $151.4M | +96.1% |
| Pre-tax Income | $154.5M | +106.7% |
| Income Tax | $39.8M | +98.1% |
| Net Income | $111.6M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $290.7M | -13.6% |
| Short-term Investments | $26.2M | +339.6% |
| Accounts Receivable | $800.9M | +3.3% |
| Current Assets | $1.22B | -9.5% |
| Total Assets | $2.27B | -6.8% |
| Current Liabilities | $1.05B | -11.3% |
| Total Liabilities | $1.19B | -10.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $258.2M | +15.1% |
| Investing Cash Flow | -$97.9M | +9.9% |
| Financing Cash Flow | -$270.5M | -83.7% |
| +109.5% |
| EPS (Basic) | $2.04 | +114.7% |
| EPS (Diluted) | $1.90 | +115.9% |
| Stockholders' Equity |
| $1.05B |
| -2.8% |